- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr Amar Bhakta Explains a New Pathway to Prevent Heart Failure Readmissions
A new pathway uses a multidisciplinary team to help reduce 30-day heart failure readmissions, explained Amar Bhakta, MD, of Rush University Medical Center.
A new pathway uses a multidisciplinary team to help reduce 30-day heart failure readmissions, explained Amar Bhakta, MD, of Rush University Medical Center.
Transcript
What was the pathway to prevent heart failure readmissions that you presented at the American Heart Association Scientific Sessions?
This pathway came about just because with the increase in healthcare costs, ways to reduce healthcare costs, especially with heart failure readmissions, I think what we found was we were able to reduce it if we developed a multidisciplinary team. And using that team over a period of 6 months, we found that we were able to reduce heart failure 30-day readmissions from 22% down to 16%.
Who are the team members in the multidisciplinary pathway and what were their roles?
The multidisciplinary team included a heart failure specialist, other physicians, pharmacists, social workers, nurses, and nurse practitioners. We designed a pathway from inpatient admission all the way up to discharge and then beyond discharge, as well, and outpatient setting, including following up with a nurse practitioner, a heart failure nurse practitioner specialist, within 7 days, and then with their PCP within 3 weeks.
Semaglutide Eligibility Expands to Over Half of US Adults
November 21st 2024Over half of the US adult population may benefit from semaglutide, a drug primarily used for weight loss and diabetes, although concerns about access and cost persist, especially considering its potential for wider health applications.
Read More
From Polypharmacy to Personalized Care: Dr Nihar Desai Discusses Holistic Cardiovascular Care
May 30th 2024In this episode of Managed Care Cast, Nihar Desai, MD, MPH, cardiologist and vice chief of Cardiology at the Yale School of Medicine, discusses therapies for cardiovascular conditions as they relate to patient adherence, polypharmacy, and health access.
Listen
Community Investment, Engagement Are Essential to Fully Address Cardiovascular Health Disparities
November 19th 2024Community-based researchers can teach clinicians a lot about how to best approach underserved populations disproportionately impacted by cardiovascular health complications.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
